Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
42
NCT05268198
SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects
Phase: Early Phase 1
Role: Lead Sponsor
Start: Mar 20, 2023
Completion: Jul 27, 2023